Acceder

Bibliografías temáticas / Interleukin-6 / Artículos de revistas

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Interleukin-6.

Artículos de revistas sobre el tema "Interleukin-6"

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 25 de julio de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Interleukin-6".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

&NA;. "Interleukin-3/interleukin-6." Reactions Weekly &NA;, no. 550 (1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

&NA;. "Interleukin-6." Reactions Weekly &NA;, no. 570 (1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Lotz, Martin. "Interleukin-6." Cancer Investigation 11, no. 6 (1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

&NA;. "Interleukin 6." Inpharma Weekly &NA;, no. 877 (1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 505 (1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 531 (1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Song, Mingchen, and John A. Kellum. "Interleukin-6." Critical Care Medicine 33, Suppl (2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ, and PETER C. HEINRICH. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, et al. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

CLARK, STEVEN C. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Olencki, Thomas, James Finke, and Ronald M. Bukowski. "Interleukin-6." Clinical Immunotherapeutics 2, no. 4 (1994): 278–94. http://dx.doi.org/10.1007/bf03258528.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Sin, Don D., and S. F. Paul Man. "Interleukin-6." Chest 133, no. 1 (2008): 4–6. http://dx.doi.org/10.1378/chest.07-2085.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Delk, Nikki A., and Mary C. Farach-Carson. "Interleukin-6." Autophagy 8, no. 4 (2012): 650–63. http://dx.doi.org/10.4161/auto.19226.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Matsuda, Tadashi, and Toshio Hirano. "Interleukin 6 (IL-6)." Biotherapy 2, no. 4 (1990): 363–73. http://dx.doi.org/10.1007/bf02170085.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Annisa, Yuanita Anggreini1 GontarAlamsyah Siregar*2 &. Leonardo Basa Dairi3. "ASSOCIATION BETWEEN INTERLEUKIN 6 SERUM LEVEL AND NON-ALCOHOLIC FATTY LIVER DISEASE." INTERNATIONAL JOURNAL OF RESEARCH SCIENCE & MANAGEMENT 6, no. 7 (2019): 11–16. https://doi.org/10.5281/zenodo.3342743.

Texto completo

Resumen

<strong>Background. </strong>Non-Alcoholic Fatty Liver Disease (NAFLD) emerged as a major health problem throughout the world and is increasing as the prevalence of obesity and diabetes continues to increase and is recognized as a major cause of liver disease-related morbidity and mortality. Adipokine is critically involved in healthy liver physiology and in the pathophysiology of acute and chronic liver disease as an intermediary for liver inflammation, liver cell death, cholestasis, and fibrosis. Interleukin-6 (IL-6) is one of adipokines widely studied recently. IL-6 showed improvement and p

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Rivera-Chavez, Fernando A., Dixie L. Peters-Hybki, Robert C. Barber, and Grant E. O'Keefe. "Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses." Shock 20, no. 3 (2003): 218–23. http://dx.doi.org/10.1097/00024382-200309000-00004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Ridker, Paul M. "Targeting Interleukin-1 and Interleukin-6." Journal of the American College of Cardiology 76, no. 15 (2020): 1774–76. http://dx.doi.org/10.1016/j.jacc.2020.08.052.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

NORTHEMANN, WOLFGANG, TODD A. BFUCIAK, MASAHIRA HATTORI, and GEORG H. FEY. "Rat Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 536–39. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24057.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Schneider, Kirsten, Reinhard Klaas, Bernd Kaspers, and Peter Staeheli. "Chicken interleukin-6." European Journal of Biochemistry 268, no. 15 (2001): 4200–4206. http://dx.doi.org/10.1046/j.1432-1327.2001.02334.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Tamura, T., N. Udagawa, N. Takahashi, et al. "Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6." Proceedings of the National Academy of Sciences 90, no. 24 (1993): 11924–28. http://dx.doi.org/10.1073/pnas.90.24.11924.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Ogawa, Michio, Kiyoshi Sakamoto, Seiji Mita, Takatoshi Ishiko, and Saburo Hisano. "INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SURGICAL TRAUMA." Shock 4, Supplement (1995): 11. http://dx.doi.org/10.1097/00024382-199512001-00045.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

De Filippo, G., D. Rendina, F. Moccia, V. Rocco, and A. Campanozzi. "Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents." Journal of Endocrinological Investigation 38, no. 3 (2014): 339–43. http://dx.doi.org/10.1007/s40618-014-0176-4.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Oka, Masaaki, Hiroshi Kusanagi, Toshihiro Saeki, et al. "Interleukin-6 Production and Interleukin-6 Receptor Expression in Human Esophageal Cancer Cell Lines." Japanese Journal of Gastroenterological Surgery 26, no. 11 (1993): 2707. http://dx.doi.org/10.5833/jjgs.26.2707.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Prens, Errol P., Klazina Benne, Jozef van Damme, et al. "Interleukin-1 and Interleukin-6 in Psoriasis." Journal of Investigative Dermatology 95, no. 6 (1990): S121—S124. http://dx.doi.org/10.1111/1523-1747.ep12874991.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Bota, Rafaqat, and Mushtaq Ahmed. "The pathophysiological profile of interleukin-6 and anti-interleukin-6 antibody." El Mednifico Journal 1, no. 2 (2013): 51. http://dx.doi.org/10.18035/emj.v1i2.26.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Ridker, Paul M., and Manas Rane. "Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease." Circulation Research 128, no. 11 (2021): 1728–46. http://dx.doi.org/10.1161/circresaha.121.319077.

Texto completo

Resumen

IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of physiological functions traditionally associated with host defense, immune cell regulation, proliferation, and differentiation. Following recognition of innate immune pathways leading from the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome to IL-1 to IL-6 and on to the hepatically derived clinical biomarker CRP (C-reactive protein), an expanding literature has led to understanding of the proatherogenic role for IL-6 in cardiovascular disease and thus the potential for IL-6 inhibitio

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Jucker, M., H. Abts, W. Li, et al. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease." Blood 77, no. 11 (1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.2413.

Texto completo

Resumen

Abstract Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific tr

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Jucker, M., H. Abts, W. Li, et al. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease." Blood 77, no. 11 (1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.bloodjournal77112413.

Texto completo

Resumen

Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Plenz, Gabriele, Heike Eschert, Michael Erren, et al. "The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts." Journal of the American College of Cardiology 39, no. 9 (2002): 1508–12. http://dx.doi.org/10.1016/s0735-1097(02)01791-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, Ivan Graber, Jacques Bienvenu, and Bernard Flourie. "Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity." Digestive Diseases and Sciences 53, no. 1 (2007): 242–47. http://dx.doi.org/10.1007/s10620-007-9849-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Angelis, Pela, Simon Scharf, Alastair Mander, Frank Vajda, and Nicholas Christophidis. "Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease." Neuroscience Letters 244, no. 2 (1998): 106–8. http://dx.doi.org/10.1016/s0304-3940(98)00136-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Rezai, Ali R., Ahmad Rezai, Otoniel Mart�nez-Maza, Meta Vander-Meyden, and Martin H. Weiss. "Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors." Journal of Neuro-Oncology 19, no. 2 (1994): 131–35. http://dx.doi.org/10.1007/bf01306454.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

MONTERO-JULIAN, F. A., E. GAUTHEROT, J. WIJDENES, B. KLEIN, and H. BRAILLY. "Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies." Journal of Interferon Research 14, no. 5 (1994): 301–2. http://dx.doi.org/10.1089/jir.1994.14.301.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

KENIS, G., C. TEUNISSEN, R. DEJONGH, E. BOSMANS, H. STEINBUSCH, and M. MAES. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM." Cytokine 19, no. 5 (2002): 228–35. http://dx.doi.org/10.1016/s1043-4666(02)91961-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Kenis, Gunter, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch, and Michael Maes. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM." Cytokine 19, no. 5 (2002): 228–35. http://dx.doi.org/10.1006/cyto.2002.1961.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

HIRANO, TOSHIO. "Interleukin 6 (IL-6) and disease." Japanese Journal of Clinical Immunology 13, no. 5 (1990): 444–45. http://dx.doi.org/10.2177/jsci.13.444.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Van Wagoner, N. J., and E. N. Benveniste. "Interleukin-6 regulation in human astrocytes: Synergy between TNF-alpha, interleukin-6, and the soluble-interleukin-6 receptor-alpha." Journal of Neuroimmunology 90, no. 1 (1998): 53. http://dx.doi.org/10.1016/s0165-5728(98)91497-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Abasova, Dunya, Sevda Kazimova, Nazrin Macidova, Telli Shirinova, and Shalala Babayeva. "STUDY OF STOKIN STATUS IN PATIENTS WITH TOXOPLASMOSIS." Annali d'Italia 50 (December 26, 2023): 17–19. https://doi.org/10.5281/zenodo.10432472.

Texto completo

Resumen

The problem of opportunistic infections is becoming an urgent problem of modern times is becoming, which is a constant increase in the number of people infected with HIV, it is related to the increase in aggressive treatment methods of oncopathologies. This infections Pathogens that can normally cause disease in healthy individuals caused by Up to 20 typical causative agents of opportunistic infections are known, and in modern infectious diseases this list is constantly growing. without symptoms: 60% - cytomegalovirus, 90% - first and second type herpavirus, 30% are toxoplasma c

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Sajjad, Kathem Ashour, Abd Jabbar Al-Ammar Haider, and Hamza Sharif Yasmine. "Interleukin-6 Biomarker as Possible Predicator of Preeclampsia." Biomedicine and Chemical Sciences, no. 4 (September 30, 2022): 306–11. https://doi.org/10.48112/bcs.v1i4.303.

Texto completo

Resumen

Preeclampsia (PE) is a serious illness that can harm both mothers and unborn children and may even be fatal. It contributes significantly to maternal fatalities in underdeveloped countries. PE, which affects 2%–3% of women who are pregnant after 20 weeks of pregnancy, is marked by proteinuria and hypertension. PE is a significant condition that plays a significant role in maternal fatalities in underdeveloped countries and is a significant cause of death for both mothers and newborns. Each year, around 60,000 maternal fatalities occur in the world. Serum interleukin-6 (IL-6) was measured

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Hoejberg, Lise, Lars Bastholt, and Henrik Schmidt. "Interleukin-6 and melanoma." Melanoma Research 22, no. 5 (2012): 327–33. http://dx.doi.org/10.1097/cmr.0b013e3283543d72.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Rose-John, Stefan. "Interleukin-6 Family Cytokines." Cold Spring Harbor Perspectives in Biology 10, no. 2 (2017): a028415. http://dx.doi.org/10.1101/cshperspect.a028415.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. "Interleukin (IL-6) Immunotherapy." Cold Spring Harbor Perspectives in Biology 10, no. 8 (2017): a028456. http://dx.doi.org/10.1101/cshperspect.a028456.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Suzuki, Kenshi, Akiko Miyashita, Yasuyuki Inoue, et al. "Interleukin-6-Producing Pheochromocytoma." Acta Haematologica 85, no. 4 (1991): 217–19. http://dx.doi.org/10.1159/000204897.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Kerr, Ron, David Stirling, and Christopher A. Ludlam. "Interleukin 6 and Haemostasis." British Journal of Haematology 115, no. 1 (2001): 3–12. http://dx.doi.org/10.1046/j.1365-2141.2001.03061.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

Nagila, Amar, Khem Raj Paudel, and Bijay Subedi. "Interleukin-6 in Hypothyroidism." Journal of Manmohan Memorial Institute of Health Sciences 9, no. 2 (2024): 27–29. http://dx.doi.org/10.3126/jmmihs.v9i2.71838.

Texto completo

Resumen

Background: Hypothyroidism means that the thyroid gland can’t produce enough thyroid hormones. Interleukin 6 (IL-6) a cytokine of innate immunity is a soluble mediator with a pleotropic effect on inflammation. Interleukin 6 test is helpful to study the hypothyroid status and to assess the adverse effects of hypothyroidism, was not studied in a tertiary care center in Pokhara, Nepal. The aim of this study is to determine the levels of interleukin 6 and to correlate with hypothyroidism. Methodology: This was a hospital based cross-sectional study on 100 hypothyroid patients where samples were co

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Sehgal, Pravinkumar B. "Interleukin-6: Molecular Pathophysiology." Journal of Investigative Dermatology 94, no. 6 (1990): s2—s6. http://dx.doi.org/10.1111/1523-1747.ep12874963.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Van Snick, Jacques. "Interleukin-6: An Overview." Annual Review of Immunology 8, no. 1 (1990): 253–78. http://dx.doi.org/10.1146/annurev.iy.08.040190.001345.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Pedersen, Bente Klarlund, Adam Steensberg, and Peter Schjerling. "Exercise and interleukin-6." Current Opinion in Hematology 8, no. 3 (2001): 137–41. http://dx.doi.org/10.1097/00062752-200105000-00002.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Patarca, Roberto, and Mary Ann Fletcher. "Interleukin-6 and Disease." Journal of Chronic Fatigue Syndrome 4, no. 1 (1998): 53–69. http://dx.doi.org/10.1300/j092v04n01_07.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

SEHGAL, PRAVIN B., LING WANG, RAVI RAYANADE, HENG PAN, and LOLA MARGULIES. "Interleukin-6-Type Cytokinesa." Annals of the New York Academy of Sciences 762, no. 1 (2006): 1–14. http://dx.doi.org/10.1111/j.1749-6632.1995.tb32309.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!